Structure Therapeutics Stock Target Price and Analyst Consensus

GPCR Stock   18.34  0.18  0.99%   
The current analyst and expert consensus on Structure Therapeutics is Strong Buy with 6 buy recommendations. The current projected Structure Therapeutics target price consensus is 76.32, with 14 analyst opinions. Structure Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Structure Therapeutics target price to derive its highest and lowest estimates based on target price estimated volatility of 3.1613. Check out Macroaxis Advice on Structure Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
69.45
Highest Forecast
84.72
Target Price
76.32
As of 07/24/2025, Gross Profit is likely to grow to about (811.5 K). At this time, Structure Therapeutics' Short Term Investments are relatively stable compared to the past year. As of 07/24/2025, Liabilities And Stockholders Equity is likely to grow to about 948.5 M, while Net Tangible Assets are likely to drop (108.8 M).
It's important to approach Structure Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Structure Therapeutics Target Price Consensus

Structure target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Structure Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   14  Strong Buy
Most Structure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Structure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Structure Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Structure Therapeutics Target Price Projection

Structure Therapeutics' current and average target prices are 18.34 and 76.32, respectively. The current price of Structure Therapeutics is the price at which Structure Therapeutics American is currently trading. On the other hand, Structure Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Structure Therapeutics Market Quote on 24th of July 2025

Low Price17.95Odds
High Price18.34Odds

18.34

Target Price

Analyst Consensus On Structure Therapeutics Target Price

Low Estimate69.45Odds
High Estimate84.72Odds

76.3214

Historical Lowest Forecast  69.45 Target Price  76.32 Highest Forecast  84.72
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Structure Therapeutics American and the information provided on this page.

Structure Therapeutics Analyst Ratings

Structure Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Structure Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Structure Therapeutics' financials, market performance, and future outlook by experienced professionals. Structure Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Structure Therapeutics price targets

Structure Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Structure Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Structure Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Structure Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Structure Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Structure Therapeutics is a key component of Structure Therapeutics valuation and have some predictive power on the future returns of a Structure Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.8418.0321.22
Details
Intrinsic
Valuation
LowRealHigh
16.1632.3435.53
Details
Naive
Forecast
LowNextHigh
15.5018.6821.87
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.13-0.4-0.27
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Power Assets Idea
Power Assets
Invested over 90 shares
Petroleum and Natural Gas Idea
Petroleum and Natural Gas
Invested over 90 shares
Giant Impact Idea
Giant Impact
Invested over 90 shares
Dividend Beast Idea
Dividend Beast
Invested over 90 shares
Information Technology ETFs Idea
Information Technology ETFs
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Banks Idea
Banks
Invested over 90 shares
ESG Investing Idea
ESG Investing
Invested few shares
Measuring and Control Equipment Idea
Measuring and Control Equipment
Invested few shares
Iron Idea
Iron
Invested over 90 shares
Robots And Drones Idea
Robots And Drones
Invested a lot of shares

Additional Tools for Structure Stock Analysis

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.